Since MEKi can trigger broad effects in, e.g., cell cycle regulation, possibly hindering the RSK‐dependent cancer cell sensitization to platinum cytotoxicity, our results warrant further RSKi investigation and development for a platinum combination. Here, RPS6KA2 is linked to cancer.